Treating multiple sclerosis and neuromyelitis optica spectrum disorder during the COVID-19 pandemic

被引：146

作者：

Brownlee, Wallace ^{[1
]}

Bourdette, Dennis ^{[2
]}

Broadley, Simon ^{[3
]}

Killestein, Joep ^{[4
]}

Ciccarelli, Olga ^{[1
,5
]}

机构：

[1] UCL Queen Sq Inst Neurol, Dept Neuroinflammat, Queen Sq MS Ctr, London, England

[2] Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97201 USA

[3] Griffith Univ, Menzies Hlth Inst Queensland, Gold Coast Campus, Nathan, Qld, Australia

[4] Univ Amsterdam, Med Ctr, Dept Neurol, Amsterdam, Netherlands

[5] Univ Coll London Hosp NIHR Biomed Res Ctr, London, England

来源：

NEUROLOGY | 2020年 / 94卷 / 22期

关键词：

D O I：

10.1212/WNL.0000000000009507

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

The emergence of novel coronavirus 2019 (COVID-19)(1)and the subsequent pandemic present a unique challenge to neurologists managing patients with multiple sclerosis (MS) and related neuroinflammatory disorders, such as neuromyelitis spectrum disorder (NMOSD).

引用

页码：949 / 952

页数：4

共 14 条

[1] A RANDOMIZED, CONTROLLED TRIAL OF CORTICOSTEROIDS IN THE TREATMENT OF ACUTE OPTIC NEURITIS [J].

BECK, RW ;

CLEARY, PA ;

ANDERSON, MM ;

KELTNER, JL ;

SHULTS, WT ;

KAUFMAN, DI ;

BUCKLEY, EG ;

CORBETT, JJ ;

KUPERSMITH, MJ ;

MILLER, NR ;

SAVINO, PJ ;

GUY, JR ;

TROBE, JD ;

MCCRARY, JA ;

SMITH, CH ;

CHROUSOS, GA ;

THOMPSON, HS ;

KATZ, BJ ;

BRODSKY, MC ;

GOODWIN, JA ;

ATWELL, CW .

NEW ENGLAND JOURNAL OF MEDICINE, 1992, 326 (09) :581-588

[2] Toward a low-cost, in-home, telemedicine-enabled assessment of disability in multiple sclerosis [J].

Bove, Riley ;

Bevan, Carolyn ;

Crabtree, Elizabeth ;

Zhao, Chao ;

Gomez, Refujia ;

Garcha, Priya ;

Morrissey, John ;

Dierkhising, Jason ;

Green, Ari J. ;

Hauser, Stephen L. ;

Cree, Bruce A. C. ;

Wallin, Mitchell T. ;

Gelfand, Jeffrey M. .

MULTIPLE SCLEROSIS JOURNAL, 2019, 25 (11) :1526-1534

[3]

Centers for Disease Control and Prevention, 2020, CHINA CDC WEEKLY

[4] Disease-modifying therapies for multiple sclerosis [J].

De Angelis, Floriana ;

John, Nevin A. ;

Brownlee, Wallace J. .

BMJ-BRITISH MEDICAL JOURNAL, 2018, 363

[5] Oral versus intravenous high-dose methylprednisolone for treatment of relapses in patients with multiple sclerosis (COPOUSEP): a randomised, controlled, double-blind, non-inferiority trial [J].

Le Page, Emmanuelle ;

Veillard, David ;

Laplaud, David A. ;

Hamonic, Stephanie ;

Wardi, Rasha ;

Lebrun, Christine ;

Zagnoli, Fabien ;

Wiertlewski, Sandrine ;

Deburghgraeve, V. Ronique ;

Coustans, Marc ;

Edan, Gilles .

LANCET, 2015, 386 (9997) :974-981

[6] Dramatically changing rates and reasons for hospitalization in multiple sclerosis [J].

Marrie, Ruth Ann ;

Elliott, Lawrence ;

Marriott, James ;

Cossoy, Michael ;

Blanchard, James ;

Tennakoon, Aruni ;

Yu, Nancy .

NEUROLOGY, 2014, 83 (10) :929-937

[7] Intensive care unit admission in multiple sclerosis Increased incidence and increased mortality [J].

Marrie, Ruth Ann ;

Bernstein, Charles N. ;

Peschken, Christine A. ;

Hitchon, Carol A. ;

Chen, Hui ;

Fransoo, Randy ;

Garland, Allan .

NEUROLOGY, 2014, 82 (23) :2112-2119

[8]

Multiple Sclerosis International Federation, GLOB COVID 19 ADV PE

[9] Risk of natalizumab-associated PML in patients with MS is reduced with extended interval dosing [J].

Ryerson, Lana Zhovtis ;

Foley, John ;

Chang, Ih ;

Kister, Ilya ;

Cutter, Gary ;

Metzger, Ryan R. ;

Goldberg, Judith D. ;

Li, Xiaochun ;

Riddle, Evan ;

Smirnakis, Karen ;

Kasliwal, Rachna ;

Ren, Zheng ;

Hotermans, Christophe ;

Ho, Pei-Ran ;

Campbell, Nolan .

NEUROLOGY, 2019, 93 (15) :E1452-E1462

[10] Meta-analysis of the Age-Dependent Efficacy of Multiple Sclerosis Treatments [J].

Weideman, Ann Marie ;

Tapia-Maltos, Marco Aurelio ;

Johnson, Kory ;

Greenwood, Mark ;

Bielekova, Bibiana .

FRONTIERS IN NEUROLOGY, 2017, 8

← 1 2 →